Home Novel serum paraoxonase activity assays are associated with coronary artery disease
Article
Licensed
Unlicensed Requires Authentication

Novel serum paraoxonase activity assays are associated with coronary artery disease

  • Nicola Martinelli , Domenico Girelli , Oliviero Olivieri , Patrizia Guarini , Antonella Bassi , Elisabetta Trabetti , Simonetta Friso , Francesca Pizzolo , Claudia Bozzini , Ilaria Tenuti , Laura Annarumma , Renzo Schiavon , Pier Franco Pignatti and Roberto Corrocher
Published/Copyright: March 11, 2009

Abstract

Background: Serum paraoxonase (PON1) exerts antiatherogenic effects. Novel PON1 enzymatic tests have been recently developed: 5-thiobutyl butyrolactone (TBBL) estimates PON1 lactonase activity, whereas 7-O-diethylphosphoryl-3-cyano-4-methyl-7-hydroxycoumarin (DEPCyMC) is considered a surrogate marker of PON1 concentration. The TBBL to DEPCyMC ratio provides the normalized lactonase activity (NLA), which may reflect the degree of PON1 lactonase catalytic stimulation. The aim of this study was to evaluate for the first time TBBLase and DEPCyMCase activity in patients with coronary artery disease (CAD).

Methods: An angiography-based case-control study was conducted, including 300 sex- and age-matched subjects [100 CAD-free, 100 CAD without myocardial infarction (MI) and 100 CAD with MI].

Results: A low DEPCyMCase activity (lowest vs. highest tertile: OR 2.96, 95% CI 1.18–7.43) and a high NLA (highest vs. lowest tertile: OR 3.25, 95% CI 1.28–8.26) were both associated with CAD, independent of classical atherosclerosis risk factors, lipid-lowering therapy and PON1 genotype. Total TBBLase activity was, however, not different in CAD compared to CAD-free subjects.

Conclusions: Novel PON1 activity assays may be associated with CAD. In this study, CAD patients had low DEPCyMCase activity, a possible marker of low PON1 concentration, but showed a high stimulation of PON1 lactonase activity.

Clin Chem Lab Med 2009;47:432–40.


Corresponding author: Nicola Martinelli, MD, Department of Clinical and Experimental Medicine, University of Verona, Policlinico G.B. Rossi, 37134 Verona, Italy Phone: +39-045-8074401, Fax: +39-045-8027473,

Received: 2008-10-8
Accepted: 2009-1-17
Published Online: 2009-03-11
Published in Print: 2009-04-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Minireview
  2. Risk loci for type 2 diabetes – Quo vadis?
  3. Genetics and Molecular Diagnostics
  4. A common variant in the FTO gene is associated with body mass index in males and postmenopausal females but not in premenopausal females. Czech post-MONICA and 3PMFs studies
  5. Genotype distribution of estrogen receptor α polymorphisms in pregnant women from healthy and preeclampsia populations and its relation to blood pressure levels
  6. Do common genetic variants in endotoxin signaling pathway contribute to predisposition to alcoholic liver cirrhosis?
  7. The selection and application of ssDNA aptamers against MPT64 protein in Mycobacterium tuberculosis
  8. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma
  9. Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow
  10. Translation termination and protein folding pathway genes are not correlated in gastric cancer
  11. General Clincial Chemistry and Laboratory Medicine
  12. Novel serum paraoxonase activity assays are associated with coronary artery disease
  13. Elevated erythrocyte carbonic anhydrase activity is a novel clinical marker in hyperventilation syndrome
  14. Elevation of the glycoxidation product Nε-(carboxymethyl)lysine in patients presenting with acute myocardial infarction
  15. Lipoprotein(a) level and its association with tumor stage in male patients with primary lung cancer
  16. A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay
  17. Reference Values and Biological Variations
  18. Minimizing the effects of multicollinearity in the polynomial regression of age relationships and sex differences in serum levels of pregnenolone sulfate in healthy subjects
  19. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
  20. Validation and Outcome Studies
  21. Analytical precision of the Urolizer® for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI
  22. Determination of nitrotyrosine concentrations in plasma samples of diabetes mellitus patients by four different immunoassays leads to contradictive results and disqualifies the majority of the tests
  23. Estimation of trueness of measurement results obtained in external quality assessment
  24. Letters to the Editor
  25. A new PCR-RFLP assay for –1123 G>C polymorphism in the PTPN22 gene: allele and genotype frequencies in a western Mexican population
  26. Proposed classification of various limit values (guide values) used in assisting the interpretation of quantitative laboratory test results
  27. Case report: Over-substitution of thyroxine due to interference in serum thyroid-stimulating hormone measurement
  28. Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis
Downloaded on 5.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.108/html?lang=en
Scroll to top button